4-(4-Benzylmorpholin-2-yl)pyrimidine-5-carboxylic acid
95%
- Product Code: 118576
CAS:
1823266-78-9
| Molecular Weight: | 299.32 g./mol | Molecular Formula: | C₁₆H₁₇N₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD27997362 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring both a morpholine and a pyrimidine moiety, makes it a valuable intermediate in the design of molecules targeting enzyme inhibition. It is often explored for its potential in modulating biological pathways, especially in the treatment of diseases where enzyme dysregulation plays a critical role, such as cancer or inflammatory disorders. Additionally, its carboxylic acid group allows for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties. Researchers also investigate its role in improving drug bioavailability and stability in medicinal chemistry applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €602.14 |
+
-
|
| 0.250 | 10-20 days | €1,139.70 |
+
-
|
4-(4-Benzylmorpholin-2-yl)pyrimidine-5-carboxylic acid
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring both a morpholine and a pyrimidine moiety, makes it a valuable intermediate in the design of molecules targeting enzyme inhibition. It is often explored for its potential in modulating biological pathways, especially in the treatment of diseases where enzyme dysregulation plays a critical role, such as cancer or inflammatory disorders. Additionally, its carboxylic acid group allows for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties. Researchers also investigate its role in improving drug bioavailability and stability in medicinal chemistry applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :